AAAAAA

   
Results: 1-13 |
Results: 13
ULTRAFLEXIBLE VESICLES, TRANSFERSOMES, HAVE AN EXTREMELY LOW PORE PENETRATION RESISTANCE AND TRANSPORT THERAPEUTIC AMOUNTS OF INSULIN ACROSS THE INTACT MAMMALIAN SKIN
Authors: CEVC G GEBAUER D STIEBER J SCHATZLEIN A BLUME G
Citation: G. Cevc et al., ULTRAFLEXIBLE VESICLES, TRANSFERSOMES, HAVE AN EXTREMELY LOW PORE PENETRATION RESISTANCE AND TRANSPORT THERAPEUTIC AMOUNTS OF INSULIN ACROSS THE INTACT MAMMALIAN SKIN, Biochimica et biophysica acta. Biomembranes, 1368(2), 1998, pp. 201-215
TRANSFERSOMES-MEDIATED TRANSEPIDERMAL DELIVERY IMPROVES THE REGIO-SPECIFICITY AND BIOLOGICAL-ACTIVITY OF CORTICOSTEROIDS IN-VIVO
Authors: CEVC G BLUME G SCHATZLEIN A
Citation: G. Cevc et al., TRANSFERSOMES-MEDIATED TRANSEPIDERMAL DELIVERY IMPROVES THE REGIO-SPECIFICITY AND BIOLOGICAL-ACTIVITY OF CORTICOSTEROIDS IN-VIVO, Journal of controlled release, 45(3), 1997, pp. 211-226
MULTIFOCAL MOTOR NEUROPATHY - SERUM IGM BINDING TO A GM1 GANGLIOSIDE-CONTAINING LIPID MIXTURE BUT NOT TO GM1 ALONE
Authors: PESTRONK A CHOKSI R BLUME G LOPATE G
Citation: A. Pestronk et al., MULTIFOCAL MOTOR NEUROPATHY - SERUM IGM BINDING TO A GM1 GANGLIOSIDE-CONTAINING LIPID MIXTURE BUT NOT TO GM1 ALONE, Neurology, 48(4), 1997, pp. 1104-1106
POLYMYOSITIS WITH CYTOCHROME-OXIDASE NEGATIVE MUSCLE-FIBERS - EARLY QUADRICEPS WEAKNESS AND POOR RESPONSE TO IMMUNOSUPPRESSIVE THERAPY
Authors: BLUME G PESTRONK A FRANK B JOHNS DR
Citation: G. Blume et al., POLYMYOSITIS WITH CYTOCHROME-OXIDASE NEGATIVE MUSCLE-FIBERS - EARLY QUADRICEPS WEAKNESS AND POOR RESPONSE TO IMMUNOSUPPRESSIVE THERAPY, Brain, 120, 1997, pp. 39-45
THE SKIN - A PATHWAY FOR SYSTEMIC TREATMENT WITH PATCHES AND LIPID-BASED AGENT CARRIERS
Authors: CEVC G BLUME G SCHATZLEIN A GEBAUER D PAUL A
Citation: G. Cevc et al., THE SKIN - A PATHWAY FOR SYSTEMIC TREATMENT WITH PATCHES AND LIPID-BASED AGENT CARRIERS, Advanced drug delivery reviews, 18(3), 1996, pp. 349-378
A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: LOTZ B BROOKS B SANJAK M WEASLER C ROELKE K PARNELL J NEVILLE H RINGEL S BRINKMANN J SINGH K BURNS D PESTRONK A LOPATE G FLORENCE J BLUME G ELIOTT J MITSUMOTO H LEVIN K SZIRONY K CALDWELL M BOSCH P SMITH B VERHEIJDE J CARR S ENGEL WK VELAZQUEZ L MILLER J GRAVES M SEPULVEDA L GARCIA S SMITH R LICHT J GILLIE E SILVERMAN L OLNEY R YUEN E MELNICK M MASS J BRADLEY W SHARMA K HURTAK L MAYOR L OLANOW CW HAUSER R MALAPIRA T OLANOW E HOPKINS L WEISSMAN J PIANTA T POLAK M SIDDIQUE T SUFIT R CASEY P ROOS R SALAZARGRUESO E RICHMAN J KASARSKIS E ENGLISH T BOTTOMS B SHEFNER J LOGIGIAN E ODAKA B CORWIN C KUNCL R ROTHSTEIN J CLAWSON L CHAUDHRY V CORNBLATH D CORSE A BROMBERG M WALD J FORSHEW D LITCHY W WINDEBANK A BUSS J CAMPION J DAUBE JR SUBRAMONY SH VEDANARAYANAN V WEAVER R CROSSWHITE T KULA R ANSELMI G RIHA T SORRENTINO C HOLMLUND T WARNER C CAMANN M MILLARD C DONNENFELD H KLEINMAN A SIVAK M ALAMPUR U HOEHL J BRATTON J JUBELT B CARY G BARRY J DRUCKER J SAMAHA F SAMS L CLARKE A SCHWIEDERMAN D MENDELL J SAHENK Z KING W DOWNING K BIRD S SCHERER S BEALE J PFOHL D HEIMANPATTERSON T SHY M SUH Y GIULIANI M LACOMIS D DECESARE S HOLBACH S FENICHEL G HOWARD J ROBISON J TANDAN R PEET P CUSIMANO S KRUSINSKI P HILLEL A SUMI M VEALE M KONIKOW N BROOKE M CWIK V BURDEN N BOYD C DASILVA B STRONG M ROWE A FINDLATER K CASHMAN N ANTEL J FINCH L BRISSETTE J FISHER MR COOK T DEMETS D BECHHOFER R YOSHIHARA D WITTES J MCKHANN G ELLENBERG J GRIGGS RC LOWENTHAL D LEVINE R STAMBLER N CHARATAN M CEDARBAUM JM
Citation: B. Lotz et al., A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS, Neurology, 46(5), 1996, pp. 1244-1249
POLYMYOSITIS WITH EXCESSIVE NUMBERS OF CYTOCHROME OXIDASE-NEGATIVE MUSCLE-FIBERS HAS CHARACTERISTIC CLINICAL-FEATURES AND A POOR RESPONSE TO PREDNISONE
Authors: BLUME G PESTRONK A JOHNS DR
Citation: G. Blume et al., POLYMYOSITIS WITH EXCESSIVE NUMBERS OF CYTOCHROME OXIDASE-NEGATIVE MUSCLE-FIBERS HAS CHARACTERISTIC CLINICAL-FEATURES AND A POOR RESPONSE TO PREDNISONE, Neurology, 46(2), 1996, pp. 1004-1004
TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES
Authors: CEVC G SCHATZLEIN A BLUME G
Citation: G. Cevc et al., TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES, Journal of controlled release, 36(1-2), 1995, pp. 3-16
ANTI-MAG ANTIBODY-ASSOCIATED POLYNEUROPATHIES - IMPROVEMENT FOLLOWINGIMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND IV-CYCLOPHOSPHAMIDE
Authors: BLUME G PESTRONK A GOODNOUGH LT
Citation: G. Blume et al., ANTI-MAG ANTIBODY-ASSOCIATED POLYNEUROPATHIES - IMPROVEMENT FOLLOWINGIMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND IV-CYCLOPHOSPHAMIDE, Neurology, 45(8), 1995, pp. 1577-1580
ANTI-MAG-ASSOCIATED POLYNEUROPATHIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND INTRAVENOUS CYCLOPHOSPHAMIDE
Authors: BLUME G PESTRONK A GOODNOUGH LT
Citation: G. Blume et al., ANTI-MAG-ASSOCIATED POLYNEUROPATHIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND INTRAVENOUS CYCLOPHOSPHAMIDE, Neurology, 45(4), 1995, pp. 170-170
DISTAL LOWER MOTOR-NEURON SYNDROMES WITH HIGH-TITER SERUM IGM ANTI-GM1 ANTIBODIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND INTRAVENOUS CYCLOPHOSPHAMIDE
Authors: PESTRONK A LOPATE G KORNBERG AJ ELLIOTT JL BLUME G YEE WC
Citation: A. Pestronk et al., DISTAL LOWER MOTOR-NEURON SYNDROMES WITH HIGH-TITER SERUM IGM ANTI-GM1 ANTIBODIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND INTRAVENOUS CYCLOPHOSPHAMIDE, Annals of neurology, 36(2), 1994, pp. 285-285
DISTAL LOWER MOTOR-NEURON SYNDROME WITH HIGH-TITER SERUM IGM ANTI-GM(1) ANTIBODIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND INTRAVENOUS CYCLOPHOSPHAMIDE
Authors: PESTRONK A LOPATE G KORNBERG AJ ELLIOTT JL BLUME G YEE WC GOODNOUGH LT
Citation: A. Pestronk et al., DISTAL LOWER MOTOR-NEURON SYNDROME WITH HIGH-TITER SERUM IGM ANTI-GM(1) ANTIBODIES - IMPROVEMENT FOLLOWING IMMUNOTHERAPY WITH MONTHLY PLASMA-EXCHANGE AND INTRAVENOUS CYCLOPHOSPHAMIDE, Neurology, 44(11), 1994, pp. 2027-2031
SPECIFIC TARGETING WITH POLY(ETHYLENE GLYCOL)-MODIFIED LIPOSOMES - COUPLING OF HOMING DEVICES TO THE ENDS OF THE POLYMERIC CHAINS COMBINES EFFECTIVE TARGET BINDING WITH LONG CIRCULATION TIMES
Authors: BLUME G CEVC G CROMMELIN MDJA BAKKERWOUDENBERG IAJM KLUFT C STORM G
Citation: G. Blume et al., SPECIFIC TARGETING WITH POLY(ETHYLENE GLYCOL)-MODIFIED LIPOSOMES - COUPLING OF HOMING DEVICES TO THE ENDS OF THE POLYMERIC CHAINS COMBINES EFFECTIVE TARGET BINDING WITH LONG CIRCULATION TIMES, Biochimica et biophysica acta, 1149(1), 1993, pp. 180-184
Risultati: 1-13 |